针对雌激素受体的PROTACs的开发:一种用于打击内分泌抵抗的新兴技术
Rouming Peng1, Xin Liu1, Chun-Chi Chen1,2
1State Key Laboratory of Biocatalysis and Enzyme Engineering, National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, School of Life Sciences, Hubei University Wuhan 430062 China guoreyting@hubu.edu.cn jianmin@hubu.edu.cn.
RSC medicinal chemistry
|January 17, 2025
概括
以雌激素受体蛋白解酶为向的嵌合体 (ER PROTACs) 提供了一种新的降解雌激素受体的策略,有可能克服ER阳性乳腺癌对内分泌疗法的耐药性. 这篇评论涵盖了它们的设计,疗效和临床试验,强调了未来的机遇和挑战.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 内分泌疗法对ER阳性乳腺癌是成功的,但面临抗药性.
- 雌激素受体 (ER) 是乳腺癌治疗的关键点.
研究的目的:
- 审查ER PROTACs的药物设计,疗效和早期临床试验.
- 突出开发ER PROTAC用于临床使用的机遇和挑战.
主要方法:
- 审查关于ER PROTACs的现有文献.
- 对ER PROTACs的药物设计原则的分析.
- 临床前和早期临床试验数据的摘要.
主要成果:
- ER PROTACs利用无素-蛋白酶体系统来降解ER.
- 这种降解机制可能会绕过常见的抵抗路径.
- 早期数据表明ER PROTACs的潜在有效性和可行性.
结论:
- 在ER阳性乳腺癌中,ER PROTAC是一种有前途的治疗策略.
- 需要进一步的研究和开发,以克服临床翻译的挑战.
- 这种新兴技术为学术和工业领域带来了重大机遇.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Internal Receptors
69.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Target Cell Response to Hormones
2.9K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
2.9K


